IS2220B - Fjölpeptíð sem geta myndað mótefnavaka bindibyggingar með sértækni fyrir resus D mótefnavökum, DNA-ið sem táknar þau og aðferðin til framleiðslu og notkunar þeirra. - Google Patents

Fjölpeptíð sem geta myndað mótefnavaka bindibyggingar með sértækni fyrir resus D mótefnavökum, DNA-ið sem táknar þau og aðferðin til framleiðslu og notkunar þeirra.

Info

Publication number
IS2220B
IS2220B IS4922A IS4922A IS2220B IS 2220 B IS2220 B IS 2220B IS 4922 A IS4922 A IS 4922A IS 4922 A IS4922 A IS 4922A IS 2220 B IS2220 B IS 2220B
Authority
IS
Iceland
Prior art keywords
antigens
resus
specificity
production
binding sites
Prior art date
Application number
IS4922A
Other languages
English (en)
Other versions
IS4922A (is
Inventor
Miescher Sylvia
Vogel Monique
Stadler Beda
Morell Andreas
Imboden Martin
Amstutz Hanspeter
Original Assignee
Zlb Behring Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zlb Behring Ag filed Critical Zlb Behring Ag
Publication of IS4922A publication Critical patent/IS4922A/is
Publication of IS2220B publication Critical patent/IS2220B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/80—Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
IS4922A 1996-06-24 1998-12-11 Fjölpeptíð sem geta myndað mótefnavaka bindibyggingar með sértækni fyrir resus D mótefnavökum, DNA-ið sem táknar þau og aðferðin til framleiðslu og notkunar þeirra. IS2220B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810421 1996-06-24
PCT/EP1997/003253 WO1997049809A1 (en) 1996-06-24 1997-06-20 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use

Publications (2)

Publication Number Publication Date
IS4922A IS4922A (is) 1998-12-11
IS2220B true IS2220B (is) 2007-03-15

Family

ID=8225636

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4922A IS2220B (is) 1996-06-24 1998-12-11 Fjölpeptíð sem geta myndað mótefnavaka bindibyggingar með sértækni fyrir resus D mótefnavökum, DNA-ið sem táknar þau og aðferðin til framleiðslu og notkunar þeirra.

Country Status (23)

Country Link
US (3) US7038020B1 (is)
EP (1) EP0920509B1 (is)
JP (1) JP3841360B2 (is)
KR (1) KR100361449B1 (is)
AT (1) ATE272116T1 (is)
AU (1) AU722127B2 (is)
BG (1) BG64534B1 (is)
BR (1) BR9709958A (is)
CA (1) CA2258494C (is)
CZ (1) CZ296807B6 (is)
DE (1) DE69730031T2 (is)
DK (1) DK0920509T3 (is)
ES (1) ES2224255T3 (is)
HU (1) HUP9902605A3 (is)
IL (1) IL127595A (is)
IS (1) IS2220B (is)
NO (1) NO327947B1 (is)
NZ (1) NZ333329A (is)
PL (1) PL186019B1 (is)
RU (1) RU2204602C2 (is)
SK (1) SK284879B6 (is)
TR (1) TR199802692T2 (is)
WO (1) WO1997049809A1 (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000029583A2 (en) * 1998-11-19 2000-05-25 Incyte Pharmaceuticals, Inc. Immunoglobulin superfamily proteins
EP1106625A1 (en) * 1999-11-17 2001-06-13 ZLB Bioplasma AG Rhesus D specific peptide sequences
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
US8288322B2 (en) 2000-04-17 2012-10-16 Dyax Corp. Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
DK2199393T3 (da) * 2000-04-17 2012-11-26 Dyax Corp Hidtil ukendte fremgangsmåder til opbygning af biblioteker over genetiske pakker, der kollektivt viser medlemmerne af en forskelligartet familie af peptider, polypeptider eller proteiner
US20030049731A1 (en) * 2000-12-05 2003-03-13 Bowdish Katherine S. Engineered plasmids and their use for in situ production of genes
AU2002249854B2 (en) 2000-12-18 2007-09-20 Dyax Corp. Focused libraries of genetic packages
AU2016225923B2 (en) * 2001-04-17 2018-07-05 Takeda Pharmaceutical Company Limited Novel Methods of Constructing Libraries Comprising Displayed and/or Expressed Members of a Diverse Family of Peptides, Polypeptides or Proteins and the Novel Libraries
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
WO2006007850A1 (en) * 2004-07-20 2006-01-26 Symphogen A/S Anti-rhesus d recombinant polyclonal antibody and methods of manufacture
RU2426795C2 (ru) 2004-07-20 2011-08-20 Симфоген А/С Способ структурной характеристики рекомбинантного поликлонального белка или поликлональной клеточной линии
GB0706558D0 (en) * 2007-04-03 2007-05-09 Common Services Agency For The Diagnostic assay
US8691730B2 (en) 2007-09-14 2014-04-08 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
US20090093004A1 (en) 2007-10-04 2009-04-09 Symphogen A/S Potency assay
US9873957B2 (en) 2008-03-13 2018-01-23 Dyax Corp. Libraries of genetic packages comprising novel HC CDR3 designs
DK2281078T3 (en) 2008-04-24 2015-02-02 Dyax Corp LIBRARIES OF RE-PACKAGES INCLUDING UNKNOWN HC-CDR1, -CDR2 AND -CDR3 AND UNKNOWN LC-CDR1, -CDR2 AND-CDR3 DESIGNS
DK3336225T3 (da) 2010-07-16 2020-03-30 Adimab Llc Antistofbiblioteker
CN104995209A (zh) * 2012-11-06 2015-10-21 米迪缪尼有限公司 使用抗假单胞菌Psl和PcrV结合分子的联合治疗
CA3079014A1 (en) * 2017-10-20 2019-04-25 Csl Ltd. Method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2127434A (en) 1982-09-17 1984-04-11 Univ London A human monoclonal antibody against Rhesus D antigen
GB8925590D0 (en) * 1989-11-13 1990-01-04 Central Blood Lab Authority Monoclonal antibodies

Also Published As

Publication number Publication date
KR20000022530A (ko) 2000-04-25
NO986088L (no) 1999-02-24
NO986088D0 (no) 1998-12-23
NO327947B1 (no) 2009-10-26
CA2258494A1 (en) 1997-12-31
DK0920509T3 (da) 2004-12-06
IS4922A (is) 1998-12-11
JP3841360B2 (ja) 2006-11-01
ES2224255T3 (es) 2005-03-01
RU2204602C2 (ru) 2003-05-20
NZ333329A (en) 2000-07-28
WO1997049809A1 (en) 1997-12-31
DE69730031D1 (de) 2004-09-02
BG64534B1 (bg) 2005-06-30
BR9709958A (pt) 1999-08-10
US7429647B2 (en) 2008-09-30
US20050266013A1 (en) 2005-12-01
BG103016A (en) 1999-08-31
AU3342397A (en) 1998-01-14
KR100361449B1 (ko) 2003-01-24
CA2258494C (en) 2008-05-27
HUP9902605A2 (hu) 1999-11-29
PL186019B1 (pl) 2003-09-30
JP2000515732A (ja) 2000-11-28
TR199802692T2 (xx) 1999-03-22
PL330794A1 (en) 1999-06-07
US7038020B1 (en) 2006-05-02
IL127595A0 (en) 1999-10-28
AU722127B2 (en) 2000-07-20
CZ395998A3 (cs) 1999-05-12
EP0920509B1 (en) 2004-07-28
EP0920509A1 (en) 1999-06-09
DE69730031T2 (de) 2005-06-16
US7399471B2 (en) 2008-07-15
HUP9902605A3 (en) 2001-11-28
SK176198A3 (en) 1999-07-12
ATE272116T1 (de) 2004-08-15
CZ296807B6 (cs) 2006-06-14
SK284879B6 (sk) 2006-01-05
IL127595A (en) 2005-09-25
US20060165694A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
IS2220B (is) Fjölpeptíð sem geta myndað mótefnavaka bindibyggingar með sértækni fyrir resus D mótefnavökum, DNA-ið sem táknar þau og aðferðin til framleiðslu og notkunar þeirra.
HK166495A (en) HIV-1 envelope muteins lacking hypervariable domains
EP0651818A4 (en) IMMUNOGENIC PEPTIDES, ANTIBODIES AND USES THEREOF IN CONNECTION WITH THE BINDING OF THE CD4 MOLECULE RECEPTOR.
HK1026911A1 (en) Novel method for the production of antihuman antigen receptors and uses thereof
TR199801722T2 (xx) Peptit imm�nojenler.
WO2001093913A3 (en) T cell receptor fusions and conjugates and methods of use thereof
IL221708A0 (en) Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response
HUP9903770A2 (hu) Eljárások és készítmények többepitópos antigének konformációjának megváltoztatására immunválasz kiváltása céljából
EP1433792A8 (en) Human receptor proteins, related reagents and methods
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
AU2002354806A1 (en) Parathyroid hormone antibodies and related methods
WO1999064461A3 (en) Monoclonal antibodies, cross-reactive antibodies and method for producing the same
WO1999013907A3 (en) Methods to improve immunogenicity of antigens and specificity of antibodies
TR200102877T2 (tr) İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar.
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
NZ500151A (en) A general method for attaching DNA molecule comprising non-antibody target molecule (eg. CTLA-4 or L-selectin), antigen or epitope sequence, and optionally a polypeptide sequence
WO2002051237A3 (en) Helicobacter proteins, nucleic acids and uses thereof
WO1999024835A3 (en) An immunoassay for procollagen-iii-c-terminal propeptide
HK1048323A1 (en) Production of mammary secretion antibodies in farmanimals
DE68926813D1 (de) Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide
MX9709446A (es) Metodo para preparar un anticuerpo monoclonal, anticuerpo monoclonal, una composicion farmaceutica y un reactivo de diagnostico.
AU7000798A (en) Pharmaceutical antigen-antibody preparation